Shares of Novo Nordisk jumped Friday after the Danish pharmaceutical giant reported positive early-stage results for its once ...
Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying ...
A self-referral service has gone live across North East and North Cumbria ICS to help manage demand for new weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback